Toxoplasma gondii: The vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice

Experimental Parasitology

Volumn 131, Issue 1, 2012, Pages 133-138

  Dziadek, Bozena ^a   Gatkowska, Justyna ^a   Grzybowski, Marcin ^a   Dziadek, Jaroslaw ^b   Dzitko, Katarzyna ^a   Dlugonska, Henryka ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Immunoprotection; Multi antigenic subunit vaccines; Recombinant Toxoplasma antigens; Toxoplasmosis

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 2; PROTEIN GRA4; PROTEIN ROP2; PROTEIN ROP4; PROTEIN SAG1; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; SUBUNIT VACCINE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMORAL IMMUNITY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTECTION; SPLEEN CELL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, SYNTHETIC;

ANIMALIA; MUS; PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84860288885     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.02.026     Document Type: Article

References (41)

1. Boothroyd J.C., Dubremetz J.F. Kiss and spit: the dual roles of Toxoplasma rhoptries. Nature Reviews Microbiology 2008, 6:79-88.
2. Buxton D. Toxoplasmosis: the first commercial vaccine. Parasitology Today 1993, 9:335-337.
3. Cui Y.-L., He S.-Y., Xue M.-F., Zhang J., Wang H.-X., Yao Y. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Parasite Immunology 2008, 30:309-313.
4. Desolme B., Mévélec M.N., Buzoni-Gatel D., Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 2000, 18:2512-2521.
5. Dlugonska H. Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. Journal of Biomedicine and Biotechnology 2008, 2008:1-7.
6. Dziadek B., Gatkowska J., Brzostek A., Dziadek J., Dzitko K., Dlugonska H. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Experimental Parasitology 2009, 123:81-89.
7. Dziadek B., Gatkowska J., Brzostek A., Dziadek J., Dzitko K., Grzybowski M., Dlugonska H. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Vaccine 2011, 29:821-830.
8. Echeverria P.C., de Miguel N., Costas M., Angel S.O. Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine 2006, 24:4102-4110.
9. Gatkowska J., Hiszczynska-Sawicka E., Kur J., Holec L., Dlugonska H. Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model. Experimental Parasitology 2006, 114:220-227.
10. Godard I., Estaquier J., Zenner L., Bossus M., Auriault C., Darcy F., Gras-Masse H., Capron A. Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Molecular Immunology 1994, 31:1353-1363.
11. Golkar M., Shokrgozar M.-A., Rafati S., Musset K., Assmar M., Sadaire R., Cesbron-Delauw M.-F., Mercier C. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 2007, 25:4301-4310.
12. Hiszczynska-Sawicka E., Li H., Xu J.B., Oledzka G., Kur J., Bickerstaffe R., Stankiewicz M. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Experimental Parasitology 2010, 124:365-372.
13. Hiszczynska-Sawicka E., Oledzka G., Holec-Gasior L., Li H., Xu J.B., Sedcole R., Kur J., Bickerstaffe R., Stankiewicz M. Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Veterinary Parasitology 2011, 177:281-289.
14. Innes E.A. A brief history and overview of Toxoplasma gondii. Zoonoses Public Health 2009, 57:1-7.
15. Jongert E., Roberts C.W., Gargano N., Förster-Wald E., Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Memorias do Instituto Oswaldo Cruz 2009, 104:252-266.
16. Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.-P., Kien T.T. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infection and Immunity 1998, 66:4503-4506.
17. Letscher-Bru V., Pfaff A.W., Abou-Bacar A., Filisetti D., Antoni E., Villard O., Klein J.-P., Candolfi E. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infection and Immunity 2003, 71:6615-6619.
18. Leyva R., Herion P., Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitology Research 2001, 87:70-79.
19. Liu S., Shi L., Cheng Y.-B., Fan G.-X., Ren H.-X., Yuan Y.-K. Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice. Parasitology Research 2009, 105:267-274.
20. Liu M.M., Yuan Z.G., Peng G.H., Zhou D.H., He X.H., Yan C., Yin C.C., He Y., Lin R.Q., Song H.Q., Zhu X.Q. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitology Research 2010, 106:1079-1084.
21. Liu Q., Shang L., Jin H., Wei F., Zhu X.-Q., Gao H. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Research in Veterinary Science 2010, 89:93-97.
22. Lourenco E.V., Bernardes E.S., Silva N.M., Mineo J.R., Panunto-Castelo A., Roque-Barreira M.-C. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes and Infection 2006, 8:1244-1251.
23. Martin V., Supanitsky A., Echeverria P.C., Litwin S., Tanos T., de Roodt A.R., Guarnera E.A., Angel S.O. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clinical and Diagnostic Laboratory Immunology 2004, 11:704-710.
24. Mevelec M.-N., Bout D., Desolme B., Marchand H., Magne R., Bruneel O., Buzoni-Gatel D. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005, 23:4489-4499.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
26. Nam H.W. GRA proteins of Toxoplasma gondii: maintenance of host-parasite interactions across the parasitophorous vacuolar membrane. Korean Journal of Parasitology 2009, 47:29-37.
27. Nie H., Fang R., Xiong B.-Q., Wang L.-X., Hu M., Zhou Y.-Q., Zhao J.-L. Immunogenicity and protective efficacy of two recombinant pseudoarabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins. Veterinary Parasitology 2011, 181:215-221.
28. Peng G.-H., Yuan Z.-G., Zhou D.-H., He X.-H., Liu M.-M., Yan C., Yin C.-C., He Y., Lin R.-Q., Zhu X.-Q. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 2009, 27:6570-6574.
29. Pernas L., Boothroyd J.C. Association of host mitochondria with the parasitophorous vacuole during Toxoplasma infection is not dependent on rhoptry proteins ROP2/8. International Journal for Parasitology 2010, 40(12):1367-1371.
30. Petersen E., Nielsen H.V., Christiansen L., Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 1998, 16:1283-1289.
31. Qu D.-F., Yu H.-J., Liu Z., Zhang D.-F., Zhou Q.-J., Zhang H.-L., Du A.-F. Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Veterinary Parasitology 2011, 179:28-34.
32. Roux-Buisson N., Fricker-Hidalgo H., Foussadier A., Rolland D., Suchel-Jambon A.S., Brenier-Pinchart M.P., Pelloux H. Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii. Diagnostic Microbiology and Infectious Disease 2005, 53:79-81.
33. Saavedra R., Becerril M.A., Dubeaux C., Lippens R., de Vos M.J., Hérion P., Bollen A. Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infection and Immunity 1996, 64:3858-3862.
34. Sanchez V.R., Pitkowski M.N., Fernandez Cuppari A.V., Rodriguez F.M., Fenoy I.M., Frank F.M., Goldman A., Corral R.S., Martin V. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 and GRA4 proteins induces protective immunity against Toxoplasma gondii infection. Experimental Parasitology 2011, 128:448-453.
35. Sinai A.P., Joiner K.A. The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane. Journal of Cell Biology 2001, 154:95-108.
36. van de Loosdrecht A.A., Beelen R.H.J., Ossenkoppele G.J., Broekhoven M.G., Langenhuijsen M.M.A.C. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. Journal of Immunological Methods 1994, 174:311-320.
37. Vercammen M., Scorza T., Huygen K., de Braekeleer J., Diet R., Jacobs D., Saman E., Verschueren H. DNA vaccination with genes encodnig Toxoplasma gondii antigens GRA1, GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice. Infection and Immunity 2000, 68:38-45.
38. Xue M., He S., Zhang J., Cui Y., Yao Y., Wang H. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Experimental Parasitology 2008, 119:352-357.
39. Yuan Z.-G., Zhang X.-X., He X.-H., Petersem E., Zhou D.-H., He Y., Lin R.-Q., Li X.-Z., Chen X.-L., Shi X.-R., Zhong X.-L., Zhang B., Zhu X.-Q. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clinical and Vaccine Immunology 2011, 18:119-124.
40. Yuan Z.-G., Zhang X.-X., Lin R.-Q., Petersen E., He S., Yu M., He X.-H., Zhou D.-H., He Y., Li H.-X., Liao M., Zhu X.-Q. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 2011, 29:6614-6619.
41. Zhang J., He S., Jiang H., Yang T., Cong H., Zhou H., Zhang J., Gu Q., Li Y., Zhao Q. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitology Research 2007, 101:331-338.